EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell Lines

Pritsana Raungrut, Suchanan Tanyapattrapong, Saowanee Maungchanburi iD, Kanyaphak Bumrungchoo

International Journal of Molecular Sciences · 28.03.2026 · 27 (7) · 3092

DOI: 10.3390/ijms27073092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.03.2026. Verfasst von Pritsana Raungrut und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai 90112, Songkhla, Thailand. Hauptthemen laut MEDLINE: Gefitinib, Drug Resistance, Neoplasm, Lung Neoplasms, Erlotinib Hydrochloride. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Science, Research, and Innovation Fund (NSRF) and Prince of Songkla University, National Science, Research, and Innovation Fund, Prince of Songkla University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Erlotinib (ER) and gefitinib (GB) are frequently prescribed for patients with advanced lung adenocarcinoma (ADC). Although both ER and GB significantly extend median survival, several patients experience early disease relapse due to treatment resistance. This study aimed to identify common genes associated with acquired resistance to ER or GB. This integrative analysis of transcriptomic data identified differentially expressed genes by comparing sensitive PC-9 cells with ER-resistant (PC-9/ER) or GB-resistant (PC-9/GB) cell lines. A Venn diagram was used to identify common genes. Candidate genes were confirmed in our generated drug-resistant cell lines. After six months, the PC-9/ER and PC-9/GB cell lines exhibited 40.7-fold and 109.2-fold increases in resistance to ER and GB, respectively. Flow cytometric analysis demonstrated that both resistant cell lines were resistant to cell cycle arrest and apoptosis induced by ER or GB. Through integrated analysis, we found that two genes, KRT13 and CEACAM5, were up-regulated in both the PC-9/ER and PC-9/GB cell lines. The expression patterns of these two genes did not align with the transcriptome, with only CEACAM5 exhibiting consistent gene and protein expressions. Our findings indicate that CEACAM5 serves as a biomarker for predicting the response of patients to ER and GB treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GefitinibDrug Resistance, NeoplasmLung NeoplasmsErlotinib HydrochlorideAdenocarcinoma of LungBiomarkers, TumorTranscriptomeCarcinoembryonic AntigenAdenocarcinomaAntigens, CDHumansCell Line, TumorGene Expression Regulation, NeoplasticGPI-Linked ProteinsGene Expression ProfilingApoptosisAntineoplastic AgentsQuinazolines

Stichwörter der Autor:innen

carcinoembryonic antigen-related cell adhesion molecule 5erlotinibgefitiniblung adenocarcinomatranscriptome

Substanzen

GefitinibErlotinib HydrochlorideBiomarkers, TumorCEACAM5 protein, humanGPI-Linked ProteinsCarcinoembryonic AntigenAntigens, CDAntineoplastic AgentsQuinazolines

Autor:innen und Institutionen

  • Division of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai 90112, Songkhla, Thailand.

ORCID-Profile: Saowanee Maungchanburi

Förderung

  • the National Science, Research, and Innovation Fund (NSRF) and Prince of Songkla University
  • National Science, Research, and Innovation Fund
  • Prince of Songkla University

Zitieren

APA

Raungrut, P., Tanyapattrapong, S., Maungchanburi, S., & Bumrungchoo, K. (2026). Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell Lines. International Journal of Molecular Sciences, 27(7), 3092. https://doi.org/10.3390/ijms27073092

Vancouver

Raungrut P, Tanyapattrapong S, Maungchanburi S, Bumrungchoo K. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell Lines. International Journal of Molecular Sciences. 2026;27(7):3092. doi:10.3390/ijms27073092

BibTeX
@article{Raungrut2026,
  author = {Raungrut, Pritsana and Tanyapattrapong, Suchanan and Maungchanburi, Saowanee and Bumrungchoo, Kanyaphak},
  title = {Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 as a Biomarker for Predicting Response to Erlotinib and Gefitinib in Lung Adenocarcinoma: An Integrative Analysis of Transcriptomic Data of PC-9 and Drug-Resistant PC-9 Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3092},
  doi = {10.3390/ijms27073092}
}
Kostenlos starten →